Please login to the form below

Not currently logged in
Email:
Password:

Baring to raise USD 450m for third India fund

Baring Private Equity Partners says it will raise USD 450m for its third India fund for strategic investments in healthcare, pharmaceutical, IT-enabled services, FMCG and alternative energy generation sectors in India

Baring Private Equity Partners (BPEP) has said it will raise USD 450m for its third India fund for strategic investments in healthcare, pharmaceutical, IT-enabled services, FMCG and alternative energy generation sectors in India.

According to Akhil Awasthi, partner at BPEP India, approximately 30 per cent of the fund will be targeted toward the healthcare and pharmaceutical sectors in the region.

BPEP's investments in over 20 companies hail from its earlier India funds of an aggregate size of USD 200m. For example, BPEP raised USD 17m for the second India fund in 2004.

Awasthi said in a press conference: "Unlike several other sectors, healthcare and pharmaceutical is an ideal industry to leverage on intellectual capital. There are various niches, technologies and market segments that one could explore. There are at least 25-30 knowledge driven companies in this sector that could go for an expansion mode on their intellectual strengths."

BPEP has so far invested in three healthcare and pharmaceutical firms, including the pharmaceutical marketing analysis and consultant company, Pharmarc.

30th September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...